Key Market Indicators
Sales of beta blocking medicines in Australia are expected to reach $130 million by 2026, growing just 0.8% year-on-year. Since 1995, the Australian market has grown 2.3% each year. In 2021, the country was the fourth biggest in the world, beaten by Canada, which recorded sales of $127 million. Italy, Canada and Australia took the top three spots in the rankings.